InterMune (ITMN)
News
| May 29 | Is Chelsea A Bad News Buy? Fool |
| May 28 | 5/29 Watch List: $GNOM $RVBD $FRO $GTAT $LEAP $UPI $CECO $ITMN $MITK $RPRX $OSG $BV $POST $NUAN $MFRM by MatthewEagen |
| May 25 | Of coUrse $ITMN only just broke 10.50 but i think it can get close to 11 today and break of that sends it to mid 11's lwhere it was last wk by epime7heus |
| May 25 | $ITMN 11 break should send it by epime7heus |
| May 25 | Healthcare Biz Recap: Rosetta Genomics Spikes, Dynasil Pops, J&J Ticks Up |
| May 24 | Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and... |
| May 22 | Sequenom's Brief, Wondrous Agreement Fool |
| May 22 | InterMune agrees to sell immune drug Actimmune |
| May 22 | InterMune to divest Actimmune, focus deal cash on lung drug |
| May 22 | InterMune to Sell Actimmune Rights |
| May 21 | any ideas about $ITMN??? by Ruslan |
| May 10 | $ITMN filed latest Quarterly Report http://stks.co/3m5s by MarketBrief |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
InterMune, Inc. is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases. It engages in therapies for the treatment of idiopathic pulmonary fibrosis, which is a lung disease. The firm's research programs are focuses on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in Brisbane, California.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). InterMune is down 71.54% over the last year vs S&P 500 Total Return up 2.32%, Idenix Pharmaceuticals up 96.98%, and ViroPharma up 7.00%.
- ITMN Total Returns
- ^SPXTR Total Returns
- IDIX Total Returns
- VPHM Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ITMN related companies
Pro Strategies Featuring ITMN
Did InterMune make it into our Pro Portfolio Strategies?
ITMN Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other ITMN Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ITMN | 10.26 | -0.84 | -7.57% | 725.16M |
| ITIC | 51.02 | +0.83 | +1.65% | 105.40M |
| ITI | 1.41 | -0.04 | -2.76% | 48.31M |
| ITC | 68.99 | -0.07 | -0.10% | 3.546B |
| ITA | 62.31 | +0.62 | +1.00% | |
| IT | 40.96 | -0.15 | -0.36% | 3.838B |
| ISTA | 9.095 | -0.01 | -0.05% | 380.11M |
| IST | 20.56 | -0.20 | -0.96% | |
| ISSI | 9.63 | -0.17 | -1.73% | 264.99M |
| ISSC | 3.54 | -0.05 | -1.39% | 58.91M |
